ACORDA THERAPEUTICS INC - COM (ACOR)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
23,978,654
Share change
-18,873,215
Total reported value
$17,609,898
Put/Call ratio
6082%
Price per share
$0.73
Number of holders
72
Value change
-$14,779,559
Number of buys
30
Number of sells
67

Institutional Holders of ACORDA THERAPEUTICS INC - COM (ACOR) as of Q2 2020

As of 30 Jun 2020, ACORDA THERAPEUTICS INC - COM (ACOR) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,978,654 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, Point72 Asset Management, L.P., ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., AQR CAPITAL MANAGEMENT LLC, FEDERATED HERMES, INC., MILLENNIUM MANAGEMENT LLC, and FMR LLC. This page lists 72 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.